Fremanezumab in the treatment of migraines: evidence to date

Calcitonin gene-related peptide (CGRP) is a major player in migraine pathophysiology, and CGRP monoclonal antibodies including fremanezumab may be a safe effective preventive therapy. Phase IIb studies in episodic migraine (EM) and chronic migraine (CM) demonstrated efficacy at both the monthly 225...

Descripción completa

Detalles Bibliográficos
Autores principales: Robblee, Jennifer, VanderPluym, Juliana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709817/
https://www.ncbi.nlm.nih.gov/pubmed/31686900
http://dx.doi.org/10.2147/JPR.S166427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709817/
https://www.ncbi.nlm.nih.gov/pubmed/31686900
http://dx.doi.org/10.2147/JPR.S166427

Ejemplares similares